Cancer BiologybioRxivPreprint
Disrupting aberrant EGFR catalytic trimers reverses T790M gefitinib resistance
Selene K. Roberts, Ioannis Galdadas, Nicola Piasentin…·Marisa L. Martin-Fernandez
This study shows that disrupting pathological EGFR catalytic trimers reverses gefitinib resistance by rewiring signaling and slowing tumor growth.
DOI 10.64898/2026.09.24.754095